A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer
Clinical trial NCT02085460 · COMPLETED
Trial details
- NCT number
- NCT02085460
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-08-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.